The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding atrial fibrillation .
Many medical device manufacturers have found themselves caught in a trap where there is a DRG and/or ZE (add-on payment) available for their technology but where the insurance companies refuse to pay this fee.
The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding rheumatoid arthritis .